222 related articles for article (PubMed ID: 26247697)
21. Biomarkers of Bad Biology: Curse or a Blessing?
Banerjee S; Sicklick JK
Ann Surg Oncol; 2019 Feb; 26(2):318-320. PubMed ID: 30539488
[No Abstract] [Full Text] [Related]
22. RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.
Indovina P; Pentimalli F; Casini N; Vocca I; Giordano A
Oncotarget; 2015 Jul; 6(20):17873-90. PubMed ID: 26160835
[TBL] [Abstract][Full Text] [Related]
23. Is Precision Medicine an Oxymoron?
Eckhardt SG; Lieu C
JAMA Oncol; 2019 Feb; 5(2):142-143. PubMed ID: 30419105
[No Abstract] [Full Text] [Related]
24. The Implications of "Random Chance" in Cancer Genesis: Why Stochastic Can Be a Dirty Word.
Meisenberg BR
JAMA Oncol; 2015 Aug; 1(5):575-6. PubMed ID: 26181509
[No Abstract] [Full Text] [Related]
25. Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies.
NicoĊ M; Wojas-Krawczyk K; Krawczyk P; Milanowski J
Adv Clin Exp Med; 2015; 24(4):715-23. PubMed ID: 26469118
[TBL] [Abstract][Full Text] [Related]
26. Visualizing Clonal Evolution in Cancer.
Krzywinski M
Mol Cell; 2016 Jun; 62(5):652-6. PubMed ID: 27259197
[TBL] [Abstract][Full Text] [Related]
27. MET receptor tyrosine kinase as a therapeutic anticancer target.
Stellrecht CM; Gandhi V
Cancer Lett; 2009 Jul; 280(1):1-14. PubMed ID: 19100682
[TBL] [Abstract][Full Text] [Related]
28. Progress and Opportunities to Advance Clinical Cancer Therapeutics Using Tumor Dynamic Models.
Bruno R; Bottino D; de Alwis DP; Fojo AT; Guedj J; Liu C; Swanson KR; Zheng J; Zheng Y; Jin JY
Clin Cancer Res; 2020 Apr; 26(8):1787-1795. PubMed ID: 31871299
[TBL] [Abstract][Full Text] [Related]
29. Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor.
Kuiper JL; Ronden MI; Becker A; Heideman DA; van Hengel P; Ylstra B; Thunnissen E; Smit EF
J Clin Pathol; 2015 Apr; 68(4):320-1. PubMed ID: 25661795
[No Abstract] [Full Text] [Related]
30. Multigene Panel Testing in Oncology Practice: How Should We Respond?
Kurian AW; Ford JM
JAMA Oncol; 2015 Jun; 1(3):277-8. PubMed ID: 26181167
[No Abstract] [Full Text] [Related]
31. [Improvement in pathological diagnosis for targeted therapy towards standardization].
Zheng J
Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):1-3. PubMed ID: 23611264
[No Abstract] [Full Text] [Related]
32. Fantastic voyage: the future of cancer diagnostics.
Sundaresan TK; Haber DA
Lancet Oncol; 2015 Dec; 16(16):1596-8. PubMed ID: 26678190
[No Abstract] [Full Text] [Related]
33. Lack of access to targeted cancer therapy.
Burki TK
Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
[No Abstract] [Full Text] [Related]
34. Crosstalk in cancer resistance and metastasis.
Norouzi S; Gorgi Valokala M; Mosaffa F; Zirak MR; Zamani P; Behravan J
Crit Rev Oncol Hematol; 2018 Dec; 132():145-153. PubMed ID: 30447920
[TBL] [Abstract][Full Text] [Related]
35. Tumor evolution: Linear, branching, neutral or punctuated?
Davis A; Gao R; Navin N
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):151-161. PubMed ID: 28110020
[TBL] [Abstract][Full Text] [Related]
36. Dodging a dogma: is treating beyond progression beneficial?
Naing A; Kurzrock R
Cancer Chemother Pharmacol; 2013 May; 71(5):1385-6. PubMed ID: 23443308
[No Abstract] [Full Text] [Related]
37. Functional evidence for Eme1 as a marker of cisplatin resistance.
Tomoda Y; Katsura M; Okajima M; Hosoya N; Kohno N; Miyagawa K
Int J Cancer; 2009 Jun; 124(12):2997-3001. PubMed ID: 19267403
[TBL] [Abstract][Full Text] [Related]
38. Recent advances and current issues in single-cell sequencing of tumors.
Sun HJ; Chen J; Ni B; Yang X; Wu YZ
Cancer Lett; 2015 Aug; 365(1):1-10. PubMed ID: 26003306
[TBL] [Abstract][Full Text] [Related]
39. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
40. Mutation and location important in cancer treatment.
Lewis R
Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321213
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
